Key result
Comorbid PAD linked to ~10% higher mortality in acute heart failure admissions vs non-PAD.
Why the study?
PAD commonly coexists with acute HF, but the short-term prognostic implications of PAD severity during HF hospitalization remain uncertain.
Does the presence and severity of peripheral artery disease worsen acute care outcomes and 30-day readmission in patients hospitalized for acute heart failure?
Cohort
Yes
Does the presence and severity of peripheral artery disease worsen acute care outcomes and 30-day readmission in patients hospitalized for acute heart failure?
Effect estimate: aOR 1.10 (95% CI 1.03-1.18)
Increasing peripheral artery disease severity in acute heart failure admissions is associated with progressively worse in-hospital outcomes, higher 30-day readmission rates, and greater resource utilization.
Heightened vigilance is warranted for acute HF with CLI; extends PAD severity data but should not yet change practice.
Peripheral artery disease (PAD) commonly coexists with acute heart failure (HF), yet the short-term prognostic implications of PAD severity during HF hospitalization are uncertain. Using nationally representative data, we queried all adult (≥18 years) index admissions with a primary diagnosis of acute HF. Cohorts were stratified into 3 groups according to PAD presence and severity using the Rutherford classification. Patients with Rutherford categories 0-3 were classified as PAD, those with categories 4-6 as critical limb ischemia (CLI), and all remaining cohorts without PAD comprised the non-PAD group. Compared with non-PAD, PAD was associated with higher adjusted odds of mortality [adjusted odds ratio (aOR), 1.10; 95% confidence interval (CI), 1.03-1.18], acute kidney injury (AKI) (aOR, 1.15; 95% CI, 1.12-1.18), cardiogenic shock (aOR, 1.13; 95% CI, 1.03-1.23), nonhome discharge (aOR, 1.15; 95% CI, 1.11-1.18), all-cause 30-day readmission (aOR, 1.21; 95% CI, 1.18-1.25), and HF readmission (aOR, 1.28; 95% CI, 1.21-1.35), as well as modestly longer length of stay by +0.39 days and higher hospitalization costs by +$500. CLI conferred markedly higher odds of mortality (aOR, 2.77; 95% CI, 2.06-3.73), cardiogenic shock (aOR, 2.31; 95% CI, 1.65-3.24), AKI (aOR, 1.41; 95% CI, 1.21-1.65), AKI requiring dialysis (aOR, 4.55; 95% CI, 2.19-9.47), and all-cause 30-day readmission (aOR, 1.59; 95% CI, 1.33-1.90), with substantially greater length of stay by +5.07 days and hospitalization costs by +$19,700. In acute HF admissions, increasing PAD severity is linked with progressively worse in-hospital outcomes and greater resource utilization, supporting early multidisciplinary inpatient management and intensified postdischarge planning for patients with PAD, particularly CLI.
No takes yet. Share an insight, caveat, or question.
Ascandar et al. (2026) conducted a cohort in Acute heart failure and peripheral artery disease. Peripheral artery disease (PAD) vs. No peripheral artery disease (non-PAD) was evaluated on Mortality (aOR 1.10, 95% CI 1.03-1.18). In acute heart failure admissions, comorbid peripheral artery disease and critical limb ischemia were associated with higher odds of mortality (aOR 1.10 and 2.77, respectively) compared to non-PAD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: